Fulcrum Therapeutics, Inc. License Agreements
3 Contracts & Agreements
- License Agreement, effective as of July 5, 2023, by and between the Registrant and CAMP4 Therapeutics Corporation (Filed With SEC on November 7, 2023)
- First Amendment to the Right of Reference and License Agreement, dated as of September 23, 2020, by and among the Registrant, GlaxoSmithKline Intellectual Property (No. 2)... (Filed With SEC on November 10, 2020)
- Right of Reference and License Agreement, dated as of February 8, 2019, by and among the Registrant, GlaxoSmithKline Intellectual Property (No. 2) Limited, GlaxoSmithKline LLC and... (Filed With SEC on June 21, 2019)
